The Usefulness of Bioelectrical Impedance Analysis in Differentiating Dyspnea Due to Decompensated Heart Failure

Journal of Cardiac Failure

Volumn 14, Issue 8, 2008, Pages 676-686

  Parrinello, Gaspare ^a   Paterna, Salvatore ^b   Di Pasquale, Pietro ^c   Torres, Daniele ^a   Fatta, Antonio ^a   Mezzero, Manuela ^a   Scaglione, Rosario ^a   Licata, Giuseppe ^a  

^a Hunter Holmes McGuire Vet Aff MC   (United States)

^b UNIVERSITY OF PALERMO   (Italy)

^c Ospedale GF Ingrassia   (Italy)

Author keywords

acute decompensated heart failure; bioelectrical impedance analysis; Dyspnea; reactance; resistance

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; DYSPNEA; ECHOCARDIOGRAPHY; EMERGENCY WARD; FEMALE; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; IMPEDANCE CARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ALGORITHMS; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; ELECTRIC IMPEDANCE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 52949093837     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.04.005     Document Type: Article

References (46)

1. McCraig L.F., and Burt C.W. National Hospital Ambulatory Medical Care Survey: 2001 Emergency Department summary. Report from Centers for Disease Control and Prevention. Advance Data from Vital and Health Statistics 335 (2003), National Center for Health Statistics, Hyattsville, MD 18
2. Bennett S.J., Huster G.A., Baker S.L., et al. Characterization of the precipitant of hospitalization for heart failure decompensation. Am J Crit Care 7 (1998) 168-174
3. Stevenson L.W. The limited availability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261 (1989) 884-888
4. Fonseca C. Diagnosis of heart failure in primary care. Heart Fail Rev 11 (2006) 95-107
5. McCaig L., and Burt C. National Hospital Ambulatory Medical Care Survey: 2002 emergency department data. ADV Data 340 (2004) 1-34
6. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 106 (2002) 416-422
7. Nagagawa O., Ogawa Y., Itoh H., et al. Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy: evidence for BNP as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 96 (1995) 1280-1287
8. Dabbah S., Reisner S.A., Aronson D., et al. Left ventricular filling hemodynamics in patients with pulmonary edema and preserved versus reduced left ventricular ejection fraction: a prospective Doppler echocardiographic study. J Am Soc Echocadiogr 19 (2006) 733-743
9. Chen H.H., and Schrier R.W. Pathophysiology of volume overload in acute heart failure syndromes. Am J Med 119 (2006) S11-S16
10. Cotter G., Moshkovitz Y., Milovanov O., et al. Acute heart failure: a novel approach to its pathogenesis and treatment. Eur J Heart Fail 4 (2002) 227-234
11. 2/R) significant in predicting total body water?. Am J Clin Nutr 56 (1992) 835-839
12. Sergy G., Bussolotto M., Perini P., et al. Accuracy of bioelectrical impedance analysis in estimation of extracellular space in healthy subject and in fluid retention states. Ann Nutr Metab 38 (1994) 158-165
13. Piccoli A., Rossi B., Pillon L., et al. A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int 46 (1994) 534-539
14. Panella C., Guglielmi F.W., Mastronuzzi T., et al. Whole-body and segmental bioelectrical parameters in chronic liver disease: effect of gender and disease stages. Hepatology 21 (1995) 352-358
15. Woodrow G., Oldroyd B., Turney J.H., et al. Segmental bioelectrical impedance in patient with chronic renal failure. Clin Nutr 15 (1996) 275-279
16. Paterna S., Di Pasquale P., Parrinello G., et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure. A double-blind study. J Am Coll Cardiol 45 (2005) 1997-2003
17. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Analysis from breathing not properly (BNP) multinational study. Circulation 106 (2002) 416-422
18. Bioelectrical impedance analysis in body composition measurement. Proceedings of a National Institutes of Health Technology Assessment Conference. Bethesda, Maryland, December 12-14, 1994. Am J Clin Nutr 64 (1996) 387S-532S
19. Baumgartner R.N., Chumlea W.C., and Roche A.F. Estimation of body composition from bioelectric impedance of body segments. Am J Clin Nutr 50 (1989) 221-226
20. Cleland J., and Dargie H. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 26 (2005) 1527-1560
21. Stevenson L.W., and Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261 (1989) 884-888
22. Vasan S., Larson M.G., Benjamin E.J., et al. Congestive heart failure in subjects with normal versus reduced ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33 (1999) 1948-1955
23. Gehlbach B.K., and Geppert E. The pulmonary manifestation of left heart failure. Chest 125 (2004) 669-682
24. Kono T., Suwa M., Hanada H., et al. Clinical significance of normal cardiac silhouette in dilated cardiomyopathy: evaluation based upon echocardiography and magnetic resonance imaging. Jpn Circ J 56 (1992) 359-365
25. Knudsen C.W., Omland T., Clopton P., et al. Diagnostic value of B-type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med 116 (2004) 363-368
26. Jimeno Sainz A., Gil V., Merino J., Garcia M., et al. Validity of Framingham criteria as a clinical test for systolic heart failure. Rev Clin Esp 206 (2006) 495-498
27. Vitarelli A., Tiukinhoy S., Di Luzio S., et al. The role of echocardiography in the diagnosis and management of heart failure. Heart Failure Rev 8 (2003) 181-189
28. Mehra M.R. Optimizing outcomes in the patients with acute decompensated heart failure. Am Heart J 151 (2006) 571-579
29. Lang C.C., Prasad N., Mcalpine H.M., et al. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J 127 (1994) 1635-1636
30. Piccoli A., Pillon L., and Dumler F. Impedance vector distribution by sex, race, body mass index, and age in the United States: standard reference intervals as bivariate Z scores. Nutrition 18 (2002) 153-167
31. Kyle U., Bosaeus I., De Lorenzo A., et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutrition 23 (2004) 1430-1433
32. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350 (1997) 1347-1351
33. O'Neill J.O., Bott-Silverman C.E., McRae A.T., et al. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am Heart J 149 (2005) 363-369
34. Davis M., Espiner E., Richards G., et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet 343 (1994) 440-444
35. Daniels L.B., Clopton P., Bhalla V., Krishnaswamy P., Nowak R.M., McCord J., et al. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J 151 (2006) 999-1005
36. Sergi G., Lupoli L., Enzi G., et al. Reliability of bioelectrical impedance methods in detecting body fluids in elderly patients with congestive heart failure. Scand J Clin Lab Invest 66 (2006) 19-30
37. Barcarse E., Kazanegra R., Chen A., et al. Combination of B-type natriuretic peptide levels and non-invasive hemodynamic parameters in diagnosing congestive heart failure in the emergency department. Congest Heart Fail 10 (2004) 171-176
38. Weiss S.J., Kulik J.P., and Calloway E. Bioimpedance cardiac output measurements in patients with presumed congestive heart failure. Acad Emerg Med 4 (1997) 568-573
39. Peacock W.F., Summers R.L., Vogel J., and Emerman C.E. Impact of impedance cardiography on diagnosis and therapy of emergent dyspnea: the ED-IMPACT trial. Acad Emerg Med 13 (2006) 365-371
40. Lo H.Y., Liao S.C., Ng C.J., et al. Utility of impedance cardiography for dyspneic patients in the ED. Am J Emerg Med 25 (2007) 437-441
41. Springfield C.L., Sebat F., Johnson D., et al. Utility of impedance cardiography to determine cardiac vs. noncardiac cause of dyspnea in the emergency department. Congest Heart Fail 10 Suppl 2 (2004) 14-16
42. Packer M., Abraham W.T., Mehra M.R., et al. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. Prospective Evaluation and Identification of Cardiac Decompensation by ICG Test (PREDICT) Study Investigators and Coordinators. J Am Coll Cardiol 47 (2006) 2245-2252
43. Ypenburg C., Bax J.J., van der Wall E.E., et al. Intrathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol 99 (2007) 554-557
44. Yu C.-M., Wang L., Chau E., et al. Intrathoracic impedance monitoring in patients with heart failure. Circulation 112 (2005) 841-848
45. Shotan A., Dacca S., and Shochat M. Fluid overload contributing to heart failure. Nephrol Dial Transplant 20 Suppl 7 (2005) 24-27
46. Cotter G., Metra M., Milo-Cotter O., et al. Fluid overload in acute heart failure-re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 10 (2008) 165-169